Search research articles
Contact Us
Filters
Showing results (61-70 of 440) with videos related to
Page
of 44
Sort By:
Clinical Allergy
|
October 1, 1982
Bronchial asthma and the neutrophil chemotactic factor
T H Lee, A B Kay
Thorax
|
April 1, 1982
Leukotrienes and lung disease
B R O'Driscoll, A B Kay
Clinical and Experimental Immunology
|
May 1, 1991
UCHL1+ (CD45RO+) 'memory' T cells predominate in the CD4+ cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects
A J Frew, A B Kay
Nature
|
October 6, 1977
The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors
A R Anwar, A B Kay
The Journal of Pharmacy and Pharmacology
|
November 1, 1974
Inhibition of eosinophil chemotaxis by the antagonist of slow reacting substance of anaphylaxis--compound FPL 55712
D G Jones, A B Kay
Clinical and Experimental Immunology
|
March 1, 1980
Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants
E J Glass, A B Kay
Clinical and Experimental Immunology
|
May 1, 1972
Antigen-antibody induced cutaneous eosinophilia in complement deficient guinea-pigs
A B Kay, K F Austen
Clinical and Experimental Immunology
|
August 1, 1972
Chemotaxis of human basophil leucocytes
A B Kay, K F Austen
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 26, 1998
Nasal immunotherapy--not to be sneezed at
B M Haselden, A B Kay
The European Respiratory Journal. Supplement
|
August 1, 1996
T-cell/eosinophil interactions in the induction of asthma
C J Corrigan, A B Kay
Page
of 44
Search research articles
Search
Showing results (61-70 of 440) with videos related to
Sort By:
Page
of 44
Clinical Allergy
|
October 1, 1982
Bronchial asthma and the neutrophil chemotactic factor
T H Lee, A B Kay
Thorax
|
April 1, 1982
Leukotrienes and lung disease
B R O'Driscoll, A B Kay
Clinical and Experimental Immunology
|
May 1, 1991
UCHL1+ (CD45RO+) 'memory' T cells predominate in the CD4+ cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects
A J Frew, A B Kay
Nature
|
October 6, 1977
The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors
A R Anwar, A B Kay
The Journal of Pharmacy and Pharmacology
|
November 1, 1974
Inhibition of eosinophil chemotaxis by the antagonist of slow reacting substance of anaphylaxis--compound FPL 55712
D G Jones, A B Kay
Clinical and Experimental Immunology
|
March 1, 1980
Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants
E J Glass, A B Kay
Clinical and Experimental Immunology
|
May 1, 1972
Antigen-antibody induced cutaneous eosinophilia in complement deficient guinea-pigs
A B Kay, K F Austen
Clinical and Experimental Immunology
|
August 1, 1972
Chemotaxis of human basophil leucocytes
A B Kay, K F Austen
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 26, 1998
Nasal immunotherapy--not to be sneezed at
B M Haselden, A B Kay
The European Respiratory Journal. Supplement
|
August 1, 1996
T-cell/eosinophil interactions in the induction of asthma
C J Corrigan, A B Kay
Page
of 44